Analyst Ratings for Avalyn Pharma (AVLN)
AVLN Rating Summary
AVLN Price Target Summary
- Highest: $80.00 (Guggenheim)
- Lowest: $52.00 (Jefferies)
- Average: $61.67
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$61.67 (+96.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
Avg. $ Target:
$61.67 (+96.1%)
* Over Last 12-Mos
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2026 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
N/A (N/A) |
28.84 (31.45) |
9.05% | Details |
| 5/26/2026 | Morgan Stanley | Judah Frommer | New Coverage | Overweight (N/A) |
53.00 (N/A) |
28.41 (31.45) |
10.7% | Details |
 |
||||||||
|
||||||||
